Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Cost of Goods Sold

Bristol-Myers Squibb Company Cost of Goods Sold Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Bristol-Myers Squibb Company Cost of Goods Sold for the quarter ending September 09, 2020 was $2,043m a 14.49% increase of 296m year over year
  • Bristol-Myers Squibb Company Cost of Goods Sold for the last 12 months ending September 09, 2020 was $8,045m a 10.25% increase of 825m year over year
  • Bristol-Myers Squibb Company Annual Cost of Goods Sold for 2019 was $7,220m a 11.23% increase of 811m from 2018
  • Bristol-Myers Squibb Company Annual Cost of Goods Sold for 2018 was $6,409m a 8.49% increase of 544m from 2017
  • Bristol-Myers Squibb Company Annual Cost of Goods Sold for 2017 was $5,865m a 15.64% increase of 917m from 2016
Other Income Statement Metrics:
  • Bristol-Myers Squibb Company EBITDA for the quarter ending December 12, 2018 was $1,907m a 15.52% increase of 296m year over year
  • Bristol-Myers Squibb Company Net Income for the quarter ending December 12, 2018 was $1,192m a -24.66% decrease of -294m year over year
  • Bristol-Myers Squibb Company Total Revenue for the quarter ending December 12, 2018 was $5,973m a 13.06% increase of 780m year over year
View Chart On Koyfin

Quarterly BMY Cost of Goods Sold Data

09/2020$2,043m
06/2020$1,971m
03/2020$2,226m
12/2019$1,747m
09/2019$1,768m
06/2019$1,833m
03/2019$1,812m
12/2018$1,592m
09/2018$1,635m
06/2018$1,611m

Annual BMY Cost of Goods Sold Data

2019$7,220m
2018$6,409m
2017$5,865m
2016$4,948m
2015$3,825m
2014$3,781m
2013$4,842m
2012$4,554m
2011$5,523m
2010$5,164m